EVAX 6-K: Fda approval
Evaxion A/S
Filed with the SEC on · accession 0001171843-26-007220
EVAX filed a 6-K (foreign company report) with the SEC on Nov 6, 2026. Evaxion A/S announced new Phase 2 biomarker data showing that its personalized cancer vaccine EVX-01 induced strong neoantigen-specific T-cell immune responses in advanced melanoma patients, with a significant association (p<0.001) between its AI-Immunology platform predictions and actual T-cell…
Summary of the filing
Evaxion A/S announced new Phase 2 biomarker data showing that its personalized cancer vaccine EVX-01 induced strong neoantigen-specific T-cell immune responses in advanced melanoma patients, with a significant association (p<0.001) between its AI-Immunology platform predictions and actual T-cell responses. The data were presented at the SITC 2026 Annual Meeting.
Key details
✦ Ask GOAX AI about this filing — what it means for EVAX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EVAX?
Click hereFrequently asked questions
What did EVAX file with the SEC on Nov 6, 2026?
EVAX filed a 6-K (Fda approval). Evaxion A/S announced new Phase 2 biomarker data showing that its personalized cancer vaccine EVX-01 induced strong neoantigen-specific T-cell immune responses in advanced melanoma patients, with a significant association (p<0.001) between its AI-Immunology platform predictions and actual T-cell responses. The data were presented at the SITC 2026 Annual Meeting.
What does a fda approval mean for EVAX stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Other EVAX SEC filings
Get alerts when EVAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days